en

PRODUCT DETAIL

FRUZAQLA 5 mg tvrdé kapsuly

Code 6707E
MA number EU/1/24/1827/002
Product Form: cps dur 21x5 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EK Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors
L01EK04 Fruquintinib
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.06.2024
Validity: 20.06.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.06.2024
eu-flag.png sk-flag.png